Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.
This chapter reviews briefly the prevalence of overexpression of the epidermal growth factor receptor in human cancers. In addition, it examines the mechanisms responsible for increased expression and its clinical significance.
Gullick
W J
WJ
ICRF Oncology Group, Royal Postgraduate Medical School, Hammersmith Hospital, London.
D066246:ErbB Receptors / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D009369:Neoplasms / Q000235:genetics*
D066246:ErbB Receptors